Chen Jiaqi, Wang Shuang, Lu Lvliang, Yang Yujie, Wang Kai, Zheng Jing, Zhou Zhijiang, Guo Pi, Cai Yunpeng, Zhang Qingying
Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China.
Shenzhen Health Development Research and Data Management Center, Shenzhen, Guangdong, China.
Front Pharmacol. 2024 Aug 15;15:1439230. doi: 10.3389/fphar.2024.1439230. eCollection 2024.
Potentially inappropriate prescribing (PIP) is commonly encountered in older adults; yet, there is limited information on the occurrence of PIP among older adults with hypertension. This study aims to determine and compare the prevalence of PIP and its association with comorbidities in older adult outpatients with hypertension across hospitals and community health centers (CHCs).
This 3-year (2015-2017) repeated cross-sectional study used electronic medical records from Shenzhen, China, involving 62 hospitals and 678 primary medical institutions. PIP was defined using the 2019 Beers Criteria. Older adults (≥65 years) with hypertension and at least one outpatient prescription were included. Modified Poisson regression analysis was used to assess the association between chronic comorbidities, healthcare settings, and PIP.
The prevalence of PIP in old adult outpatients with hypertension in 2015, 2016, and 2017 was 46.32%, 46.98%, and 46.58% in hospitals, with a sample size of 38,411, 46,235, and 50,495, respectively, and 29.14%, 26.66%, and 29.84% in CHCs, with a sample size of 26,876, 29,434, and 34,775 respectively. The top four most popular PIP in hospitals and CHCs was proton-pump inhibitors (PPIs), diuretics, benzodiazepines, and non-cyclooxygenase-selective non-steroidal anti-inflammatory drugs (NSAIDs), respectively. PIP was most associated with chronic gastrointestinal disease (adjusted prevalence ratio = 1.54, 95% confidence interval [CI] = 1.50-1.59) and mental and behavioral disorders (adjusted prevalence ratio = 1.49, 95% CI = 1.46-1.53) in hospitals and with mental and behavioral disorders (adjusted prevalence ratio = 1.99; 95% CI = 1.95-2.03) and musculoskeletal system and connective tissue disorders (adjusted prevalence ratio = 1.33; 95% CI = 1.31-1.36) in CHCs. The prevalence of PIP was significantly higher in hospital settings than in CHCs (adjusted prevalence ratio = 1.65; 95% CI = 1.63-1.66).
Among older adult outpatients with hypertension in Shenzhen, PIP was more prevalent in hospitals than in CHCs. The comorbidities most strongly associated with PIP were chronic gastrointestinal disease and mental and behavioral disorders in hospitals and mental and behavioral disorders in CHCs. Clinical pharmacy integration needs to be considered to reduce inappropriate prescribing in this vulnerable population.
老年人中潜在不适当处方(PIP)现象普遍存在;然而,关于高血压老年患者中PIP发生情况的信息有限。本研究旨在确定并比较高血压老年门诊患者中PIP的患病率及其与合并症的关联,这些患者来自医院和社区卫生中心(CHC)。
这项为期3年(2015 - 2017年)的重复横断面研究使用了来自中国深圳的电子病历,涉及62家医院和678家基层医疗机构。PIP采用2019年《Beers标准》进行定义。纳入年龄≥65岁、患有高血压且至少有一张门诊处方的老年人。采用修正泊松回归分析评估慢性合并症、医疗机构类型与PIP之间的关联。
2015年、2016年和2017年,医院中高血压老年门诊患者的PIP患病率分别为46.32%、46.98%和46.58%,样本量分别为38411、46235和50495;CHC中分别为29.14%、26.66%和29.84%,样本量分别为26876、29434和34775。医院和CHC中最常见的四种PIP分别是质子泵抑制剂(PPI)、利尿剂、苯二氮䓬类药物和非环氧化酶选择性非甾体抗炎药(NSAIDs)。在医院中,PIP与慢性胃肠疾病(调整患病率比 = 1.54,95%置信区间[CI] = 1.50 - 1.59)和精神及行为障碍(调整患病率比 = 1.49,95%CI = 1.46 - 1.53)关联最强;在CHC中,与精神及行为障碍(调整患病率比 = 1.99;95%CI = 1.95 - 2.03)和肌肉骨骼系统及结缔组织疾病(调整患病率比 = 1.33;95%CI = 1.31 - 1.36)关联最强。医院环境中PIP的患病率显著高于CHC(调整患病率比 = 1.65;95%CI = 1.63 - 1.66)。
在深圳高血压老年门诊患者中,PIP在医院中的患病率高于CHC。与PIP关联最密切的合并症在医院中是慢性胃肠疾病和精神及行为障碍,在CHC中是精神及行为障碍。需要考虑整合临床药学以减少这一脆弱人群中的不适当处方。